News – Page 529 – Endpoints News

AbbVie expands use of real patients in latest Allergan Aesthetics DTC campaign

4 years ago

House committee unanimously advances FDA user fee legislation with accelerated approval tweaks

4 years ago

New FTC commissioner could turn the tide for an investigation into PBMs

4 years ago

Federal judge weighs motion to dismiss HeLa lawsuit against Thermo Fisher

4 years ago

Pfizer, Sarepta and two others suggest Duchenne drug safety issues tied to "class effect"

4 years ago

After laying off a fourth of its staff, gene therapy startup SwanBio sees fresh financing as it heads towards the ...

4 years ago

Moderna starts up third HIV vaccine trial, partnering with IAVI to study its shot in Africa

4 years ago

Flagship builds a new startup out of pieces from 2 of its biotechs. And a Roche vet leaves to do something new

4 years ago

Less than two years after nine-figure IPO, Applied Molecular Transport cuts back on staff, pipeline efforts

4 years ago

Locus pulls in a modest Series B as it attempts to emulate oncology's precision medicine model in antibacterials

4 years ago

With seizure drug held up at FDA again, Aquestive replaces longtime CEO

4 years ago

Chinese pharma giant Hengrui launches new company for globalization play — with a Merck KGaA vet at the helm

4 years ago

Under-the-radar Chinese biotech scores $47M upfront in secretive Merck deal around cancer drug

4 years ago

Senate user fee reauthorization bill omits accelerated approval reforms, shows wide gaps with House version

4 years ago

As new C. diff treatments prep for market, specialists divided on 'poop in a pill' or small molecule, study finds

4 years ago

Berkshire Hathaway pulls out of AbbVie, Bristol Myers Squibb investments

4 years ago

Long-expected UK layoffs imminent for Novartis following sale

4 years ago

FDA authorizes booster dose of Pfizer and BioNTech's Covid-19 vaccine in 5- to 11-year-olds

4 years ago

Greece goes on offensive against Novartis, filing a lawsuit in aftermath of bribery scheme

4 years ago

FDA lobbies Congress over rare disease court ruling with wide implications

4 years ago

Even FDA's Peter Marks is worried about the commercial viability of gene and cell therapies

4 years ago

Pricy inhalers remain expensive due to device tweaks that keep competitors at bay, researchers find

4 years ago

MRx roundup: Hologic enlists Sheryl Crow for screenings; J&J QuickFire teams with feds for public health

4 years ago

Perpetual crisis? Pharma communications and public relations pros just wait for the next shoe to drop

4 years ago

First page Previous page 526 527 528529530 531 532 Next page Last page